Skip to content

Author

T. Rutkowski

We have 3 of 20 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Circulating tumor HPV DNA reappearance as an early indicator of recurrence after radiotherapy-based treatment for HPV-associated oropharyngeal cancer: analysis of more than 2000 assessments in 232 patients.

BACKGROUND Circulating tumor human papillomavirus DNA (ctHPV DNA) is a promising blood-based surveillance biomarker in HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) and head-and-neck carcinoma of unknown primary (CUP). This study aimed to evaluate the diagnostic performance of ctHPV DNA-based molecular tes...

I. Jabłońska, T. Rutkowski, U. Kacorzyk et al. · 1 citation
Open access Aug 2026

Clinical Implications of Nutritional Consultations and Oral Nutritional Supplementation Refusal in Head and Neck Cancer Patients During Chemoradiotherapy

The study demonstrates that while NCONS minimizes overall complications during CHRT, its refusal results in weight loss, elevated CRP and depleted prealbumin levels, and a more frequent need for enteral nutrition interventions.

A. Krzywon, Anna Kotylak, J. Mrochem-Kwarciak et al. · 0 citations
Open access Jul 2026

Hypertension is the most common cardiovascular risk factor in cancer patients - data from the CONNECT-POL registry.

The prevalence of hypertension in cancer patients is very high compared to the general population and varies by cancer type, being highest in colorectal cancer and lowest in breast cancer patients.

Katarzyna Styczkiewicz, M. Tajstra, Aleksandra Liżewska-Springer et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.